Oncolytic Vaccinia Virotherapy of Anaplastic Thyroid Cancer in Vivo

Context: Anaplastic thyroid carcinoma (ATC) is a fatal disease with a median survival of only 6 months. Novel therapies are needed to improve dismal outcomes. Objective: A mutated, replication-competent, vaccinia virus (GLV-1h68) has oncolytic effects on human ATC cell lines in vitro. We assessed th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lin, Shu-Fu, Price, Daniel L., Chen, Chun-Hao, Brader, Peter, Li, Sen, Gonzalez, Lorena, Zhang, Qian, Yu, Yong A., Chen, Nanhai, Szalay, Aladar A., Fong, Yuman, Wong, Richard J.
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2008
Matèries:
Endocrine Care
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3728375/
https://ncbi.nlm.nih.gov/pubmed/18697871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2008-0316
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars